查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1392096

臨床診斷市場：依產品類型、最終使用者類型、應用、地區

Physician Office Diagnostic Market, By Product Type (Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics, and Urinalysis Systems), By End User, By Application, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 165 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2023年全球臨床診斷市場規模為1,044.7億美元，2023年至2030年年複合成長率（CAGR）為13.8%，預計2030年將達到2,582.1億美元。

報告範圍 報告詳情
基準年 2022年 2023年市場規模 1044.7億美元
實績資料 2018-2021 預測期 2023-2030
預測期年複合成長率 13.80% 2030年市場規模預測 2582.1億美元
圖 1. 2023 年按地區分類的臨床診斷全球市場佔有率(%)
醫師辦公室診斷市場-IMG1

POCT 可實現快速、準確的診斷測試並立即提供結果，幫助醫生和患者盡快遠端做出治療決策。為了協助診斷、監測和管理各種醫療狀況，醫生辦公室、診所和門診診所使用各種被歸類為「診所診斷」的醫療設備、裝置和測試。這些診斷對於快速且準確的醫療決策、改善病患治療結果以及提高醫療保健服務的有效性至關重要。

市場動態

對現場檢測的需求不斷成長、對預防性醫療保健的重視以及診斷設備的技術進步預計將在預測期內推動全球臨床診斷市場的成長。此外，對個人化醫療的日益關注預計也將推動預測期內全球醫療診斷市場的成長。床邊檢測的擴展、分子診斷的進步、數位健康解決方案的整合以及新興市場的擴展預計將為預測期內的全球臨床診斷市場提供成長機會。

然而，監管和合規挑戰、技術複雜性和操作員技能預計將阻礙預測期內全球臨床診斷市場的成長。

本研究的主要特點

  • 該報告對全球臨床診斷市場進行了詳細分析，並提供了以2022年為基準年的預測期（2023-2030）的市場規模和年複合成長率（CAGR%）。
  • 它還揭示了各個細分市場的潛在商機，並為該市場說明了一系列有吸引力的投資提案。
  • 它還提供了有關市場促進因素、抑制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要考察。
  • 它根據公司亮點、產品系列、主要亮點、績效和策略等參數，介紹了全球醫師辦公室診斷市場的主要企業。
  • 該報告的見解使行銷人員和經營團隊負責人就未來的產品發布、類型升級、市場擴張和行銷策略做出資訊的決策。
  • 本研究報告針對該產業的各個相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
  • 透過用於分析全球臨床診斷市場的各種策略矩陣，將有助於相關人員做出決策。

目錄

第1章 研究目的與前提

  • 研究目標
  • 假設
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map（COM）

第3章 市場動態、法規及趨勢分析

  • 市場動態
  • 影響分析
  • 主要亮點
  • 監管場景
  • 產品發布/核准
  • PEST分析
  • 波特的分析
  • 併購場景

第4章 全球臨床診斷市場－冠狀病毒(COVID-19) 大流行的影響

  • 新型冠狀病毒感染疾病（COVID-19）的流行病學
  • 供需面分析
  • 經濟影響

第5章 全球臨床診斷市場，依產品類型，2018-2030

  • 即時檢測 (POCT) 設備
  • 臨床生化分析儀
  • 免疫檢測系統
  • 分子診斷
  • 尿液檢查系統

第6章 全球臨床診斷市場，依最終使用者類型，2018-2030

  • 醫務室/診所
  • 急診中心
  • 門診治療中心

第7章 全球臨床診斷市場（按應用），2018-2030

  • 感染疾病
  • 心血管疾病
  • 代謝紊亂
  • 癌症診斷
  • 懷孕/生育力測試

第8章 全球臨床診斷市場，按地區，2018-2030

  • 北美洲
  • 美國
  • 加拿大
  • 歐洲
  • 英國
  • 德國
  • 義大利
  • 法國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 中國
  • 印度
  • 日本
  • ASEAN
  • 澳洲
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲
  • 中東
  • GCC
  • 以色列
  • 其他中東地區
  • 非洲
  • 北非
  • 中部非洲
  • 南非

第9章 競爭形勢

  • F. Hoffmann-La Roche Ltd
  • Siemens Healthineers AG
  • Abbott Laboratories
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Sysmex Corporation
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Quidel Corporation
  • Hologic, Inc.
  • Ortho Clinical Diagnostics
  • Beckman Coulter, Inc.（a subsidiary of Danaher Corporation）
  • BioMerieux SA
  • Trinity Biotech plc
  • EKF Diagnostics Holdings plc

第10章 章

  • 調查方法
  • 關於出版商
簡介目錄
Product Code: CMI6031

The Global Physician Office Diagnostic Market size was valued at US$ 104.47 billion in 2023 and is expected to reach US$ 258.21 billion by 2030, growing at a Compound Annual Growth Rate (CAGR) of 13.8% from 2023 to 2030.

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 104.47 Bn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 13.80% 2030 Value Projection: US$ 258.21 Bn
Figure 1. Global Physician Office Diagnostic Market Share (%), by Region, 2023
Physician Office Diagnostic Market - IMG1

POCT enables quick and accurate diagnostic testing with immediate results, assisting doctors and patients in making decisions about care remotely and as soon as feasible. In order to help with the diagnosis, monitoring, and management of various medical diseases, physician offices, clinics, and ambulatory care facilities use a variety of medical devices, equipment, and tests that fall under the category of "physician office diagnostics." These diagnostics are essential for prompt and accurate medical decision-making, better patient outcomes, and increased healthcare delivery effectiveness.

Market Dynamics

Increasing demand for point-of-care testing, emphasis on preventive healthcare, and technological advancements in diagnostic devices are anticipated to drive growth of the global physician office diagnostic market over the forecast period. Moreover, increasing focus on personalized medicine is also expected to boost growth of the global physician office diagnostic market over the forecast period. Expansion of point-of-care testing, advances in molecular diagnostics and integration of digital health solutions, and expansion in emerging markets are expected to create growth opportunities for the global physician office diagnostic market during the forecast period.

However, regulatory and compliance challenges and technical complexity and operator skill are expected to hamper growth of the global physician office diagnostic market over the forecast period.

Key features of the study:

  • This report provides in-depth analysis of the global physician office diagnostic market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global physician office diagnostic market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include F. Hoffmann-La Roche Ltd, Siemens Healthineers AG, Abbott Laboratories, Thermo Fisher Scientific Inc., Danaher Corporation, Sysmex Corporation, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Quidel Corporation, Hologic, Inc., Ortho Clinical Diagnostics, Beckman Coulter, Inc. (a subsidiary of Danaher Corporation), BioMerieux SA, Trinity Biotech plc, EKF Diagnostics Holdings plc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global physician office diagnostic market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global physician office diagnostic market

Physician Office Diagnostic Market Detailed Segmentation:

  • By Product Type:
    • Point-of-Care Testing (POCT) Devices
    • Clinical Chemistry Analyzers
    • Immunoassay Systems
    • Molecular Diagnostics
    • Urinalysis Systems
  • By End User
    • Physician Offices and Clinics
    • Urgent Care Centers
    • Ambulatory Care Centers
  • By Application
    • Infectious Diseases
    • Cardiovascular Disorders
    • Metabolic Disorders
    • Cancer Diagnosis
    • Pregnancy and Fertility Testing
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • South Africa
  • Top companies in Physician Office Diagnostic Market
    • F.Hoffmann-La Roche Ltd
    • Siemens Healthineers AG
    • Abbott Laboratories
    • Thermo Fisher Scientific Inc.
    • Danaher Corporation
    • Sysmex Corporation
    • Becton, Dickinson and Company
    • Bio-Rad Laboratories, Inc.
    • Quidel Corporation
    • Hologic, Inc.
    • Ortho Clinical Diagnostics
    • Beckman Coulter, Inc. (a subsidiary of Danaher Corporation)
    • BioMerieux SA
    • Trinity Biotech plc
    • EKF Diagnostics Holdings plc

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Physician Office Diagnostic Market, By Product Type
    • Global Physician Office Diagnostic Market, By End User
    • Global Physician Office Diagnostic Market, By Application
    • Global Physician Office Diagnostic Market, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Increasing demand for point-of-care testing
    • Regulatory and compliance challenges
    • Advancements in molecular diagnostics
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Physician Office Diagnostic Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Physician Office Diagnostic Market, By Product Type, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Point-of-Care Testing (POCT) Devices
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Clinical Chemistry Analyzers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Immunoassay Systems
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Molecular Diagnostics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Urinalysis Systems
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

6. Global Physician Office Diagnostic Market, By End User Type, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Physician Offices and Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
  • Urgent Care Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
  • Ambulatory Care Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)

7. Global Physician Office Diagnostic Market, By Application, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Infectious Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
  • Cardiovascular Disorders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
  • Metabolic Disorders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
  • Cancer Diagnosis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
  • Pregnancy and Fertility Testing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)

8. Global Physician Office Diagnostic Market, By Region, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Region, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, For Region 2018 - 2030
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country/Sub-region, 2018-2030, (US$ Bn)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country/Sub-region, 2018-2030, (US$ Bn)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country/Sub-region, 2018-2030, (US$ Bn)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country/Sub-region, 2018-2030, (US$ Bn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country/Sub-region, 2018-2030, (US$ Bn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country/Sub-region, 2018-2030, (US$ Bn)
  • North Africa
  • Central Africa
  • South Africa

9. Competitive Landscape

  • F. Hoffmann-La Roche Ltd
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Siemens Healthineers AG
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Abbott Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Thermo Fisher Scientific Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Danaher Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Sysmex Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Becton, Dickinson and Company
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Bio-Rad Laboratories, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Quidel Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Hologic, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Ortho Clinical Diagnostics
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Beckman Coulter, Inc. (a subsidiary of Danaher Corporation)
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • BioMerieux SA
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Trinity Biotech plc
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • EKF Diagnostics Holdings plc
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Analyst Views

10. Section

  • Research Methodology
  • About us